Welcome to the sixth newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Welcome to the fifth newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Welcome to the fourth newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Complete the learning modules to challenge your knowledge and access the latest research and recommendations for effective and safe clinical management of adults with dyslipidaemia.
Prof. Michel Farnier discusses "Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING)".
Welcome to the third newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Welcome to the second newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
